11
December
2019
|
00:00
Europe/Amsterdam

Gentle packaging of breast implants

Covestro special films are transparent, tear-resistant and easy to process

Medical packaging is a huge market segment within the medical industry. Many different materials and solutions compete across all applications. Covestro is particularly focused on premium packaging materials for high value medical devices that meet increased requirements for mechanical protection, sterilization and dimensional stability.

Breast implants are sensitive products that should arrive undamaged at the treating doctor or hospital after manufacture, sterilization and transport. Covestro's Makrofol® MA507 polycarbonate film is well suitable for their packaging because it is highly transparent and allows the physician to reliably visually inspect the implant before unpacking it. It also provides stable protection for the valuable medical device. The comparable product Makrofol® MA336 offers the same advantages, but also features a laminating film on it.

Both films are characterized by high tear and impact resistance. They can be easily thermoformed and are fully compatible with the demanding autoclave sterilization process, where they need to withstand temperatures of up to 163 degrees Celsius. Both materials meet the ISO 9001:2015 quality management standard and two ASTM standard specifications for implantable breast prosthesis certification.

 

Boilerplate

About Covestro:

With 2018 sales of EUR 14.6 billion, Covestro is among the world’s largest polymer companies. Business activities are focused on the manufacture of high-tech polymer materials and the development of innovative solutions for products used in many areas of daily life. The main segments served are the automotive, construction, wood processing and furniture, and electrical and electronics industries. Other sectors include sports and leisure, cosmetics, health and the chemical industry itself. Covestro has 30 production sites worldwide and employs approximately 16,800 people (calculated as full-time equivalents) at the end of 2018.
 

Forward-looking statements

This news release may contain forward-looking statements based on current assumptions and forecasts made by Covestro AG. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Covestro’s public reports which are available at www.covestro.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.